Rapamycin, not cyclosporine, permits thymic generation and peripheral preservation of CD4+ CD25+ FoxP3+ T cells (Q79919091)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17351648%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

title

Rapamycin, not cyclosporine, permits thymic generation and peripheral preservation of CD4+ CD25+ FoxP3+ T cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17351648%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17351648%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

author name string

Coenen JJ

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17351648%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Koenen HJ

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17351648%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

van Rijssen E

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17351648%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Kasran A

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17351648%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Boon L

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17351648%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Joosten I

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17351648%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

publication date

12 March 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17351648%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

27 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17351648%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17351648%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17351648%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

page(s)

537-545

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17351648%20AND%20SRC:MED&resulttype=core&format=json

Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease

27 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705628

7 January 2021

Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705628

7 January 2021

Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705628

7 January 2021

CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705628

7 January 2021

CD4+CD25+ regulatory T lymphocytes in bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705628

7 January 2021

CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705628

7 January 2021

A function for interleukin 2 in Foxp3-expressing regulatory T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705628

7 January 2021

Development and function of agonist-induced CD25+Foxp3+ regulatory T cells in the absence of interleukin 2 signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705628

7 January 2021

Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705628

7 January 2021

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705628

7 January 2021

Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705628

7 January 2021

Regulatory T cells in immunologic self-tolerance and autoimmune disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705628

7 January 2021

Mechanisms of action of cyclosporine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705628

7 January 2021

Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705628

7 January 2021

Immunopharmacology of rapamycin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705628

7 January 2021

Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705628

7 January 2021

Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705628

7 January 2021

Interleukin-2 receptor α chain regulates the size and content of the peripheral lymphoid compartment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705628

7 January 2021

The IL-2 receptor beta chain (p70): role in mediating signals for LAK, NK, and proliferative activities

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705628

7 January 2021

Differential effects of cyclosporin-A and rapamycin on in vivo thymocyte maturation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705628

7 January 2021

An intersection between the self-reactive regulatory and nonregulatory T cell receptor repertoires

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705628

7 January 2021

T-cell development and the CD4-CD8 lineage decision

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705628

7 January 2021

Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705628

7 January 2021

Continuous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705628

7 January 2021

Multiple effects of cyclosporin A on the thymus in relation to T-cell development and autoimmunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705628

7 January 2021

A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705628

7 January 2021

LAT-mediated signaling in CD4+CD25+ regulatory T cell development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705628

7 January 2021

Developmental regulation of Foxp3 expression during ontogeny.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705628

7 January 2021

Molecular mechanisms underlying FOXP3 induction in human T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705628

7 January 2021

Cyclosporin-A differentially affects apoptosis during in vivo rat thymocyte maturation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705628

7 January 2021

Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705628

7 January 2021

Distinct IL-2 receptor signaling pattern in CD4+CD25+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705628

7 January 2021

Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705628

7 January 2021

The influence of immunosuppressive drugs on tolerance induction through bone marrow transplantation with costimulation blockade

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705628

7 January 2021

Differential effects of cyclosporine A, methylprednisolone, mycophenolate, and rapamycin on CD154 induction and requirement for NFkappaB: implications for tolerance induction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705628

7 January 2021

Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705628

7 January 2021

Tolerance to cyclosporin A-induced autologous graft-versus-host disease is mediated by a CD4+CD25+ subset of recent thymic emigrants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705628

7 January 2021

The balance of deletion and regulation in allograft tolerance.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705628

7 January 2021

High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705628

7 January 2021

Association of Foxp3 regulatory gene expression with graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705628

7 January 2021

Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHD.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705628

7 January 2021